Privitar secures £31.44 million Series B investment led by Accel

[London, United Kingdom / Boston, USA, Monday 10th June 2019]

Privitar, the data privacy software company, announced it has closed a $40 million Series B funding round led by global venture capital firm Accel, with participation from existing investors Partech, Salesforce Ventures, 24Haymarket and IQ Capital.

The investment strengthens the company’s leadership position in the global data privacy market. Seth Pierrepont, Partner at Accel, will join Privitar’s board of directors.

Data privacy is now top of mind. Following high-profile events like the Equifax breach and the Cambridge Analytica scandal, consumers around the world are increasingly concerned with how enterprises are handling their personal data. Additionally, regulation and consumer rights around data protection are growing, with the introduction of General Data Protection Regulation (GDPR) in Europe and California Consumer Privacy Act (CCPA) in the United States.

Privitar will use the investment to accelerate the development of its privacy engineering products, providing a comprehensive set of capabilities that will enable its customers to publish and share valuable data-driven insights in an efficient, trustworthy, and compliant way. Its customers include some of the world’s best-known brands, such as HSBC, the UK’s National Health Service (NHS Digital) and BT.

Jason du Preez, Privitar’s CEO said: “The world is increasingly aware of the importance of protecting private information and privacy engineering is becoming intrinsic to the way organizations manage and share data.

“This investment will enable us to scale rapidly in response to global demand and help our customers realise the enormous benefits of data-driven decision making, much faster and with less risk.”

Seth Pierrepont from Accel added: “There has been a noticeable increase in enterprises’ appetite for buying data privacy technology in recent years. Through the team’s deep domain expertise and close ties to academia, Privitar has positioned itself as a thought leader in privacy innovation. We’re excited to be joining Privitar on its mission of becoming the standard for enterprise data privacy.”

The company is well positioned as an emerging leader in this category and has seen huge demand for its products as organizations seek the latest technology to analyse their data safely, and with the utmost respect for the individual. Across industries, from banks seeking to improve customer service while protecting personal financial information to healthcare providers seeking to improve clinical outcomes while protecting patient data, it is essential for organizations to harness the power of data, while maintaining the trust they have with their customers.

Ends

Press contact

For further information please contact:

Clementine Boyer Duroselle on the Privitar press team: cboyerduroselle@privitar.com, +44 7932774644

Josephine Salm for Accel: josephine@sepiacommunications.com

About Privitar

Privitar provides data-privacy software to companies and public sector organizations around the world to protect sensitive data and enable the safe and ethical use of data for insight. Privitar was established in 2014 with headquarters in London. The business expanded overseas in 2018 and 2019, opening offices in New York, Boston, Paris, Munich and Singapore. Privitar raised $16m in a Series A funding round in July 2017, with support from existing investors IQ Capital, 24 Haymarket and Illuminate Financial and new funding from Partech, CME Ventures and Salesforce Ventures.

Privitar hosts an annual community event – In:Confidence – with luminary privacy experts and commentators and contributes regularly to the public discourse on privacy matters. You can read and subscribe to the latest news and opinions from Privitar here.

For more information, please visit www.privitar.com

About Accel

Accel is a leading venture capital firm that partners with exceptional founders with unique insights, from inception through all phases of private company growth. Atlassian, Algolia, Avito, Celonis, Cloudera, Crowdstrike, Deliveroo, DJI, Dropbox, Etsy, Facebook, Flipkart, Funding Circle, Kayak, Kry, QlikTech, Rovio, Slack, Spotify, Supercell, UIPath and WorldRemit are among the companies the firm has backed over the past 35+ years. The firm seeks to understand entrepreneurs as individuals, appreciate their originality and play to their strengths. Because greatness doesn’t have a stereotype. For more, visit www.accel.comwww.facebook.com/accel or www.twitter.com/accel.

Salesforce Ventures

Salesforce is the fastest growing top five enterprise software company and the #1 CRM provider globally. Salesforce Ventures—the company’s corporate investment group—invests in the next generation of enterprise technology that extends the power of the Salesforce Customer Success Platform, helping companies connect with their customers in entirely new ways. Portfolio companies receive funding as well as access to the world’s largest cloud ecosystem and the guidance of Salesforce’s innovators and executives. With Salesforce Ventures, portfolio companies can also leverage Salesforce’s expertise in corporate philanthropy by joining Pledge 1% to make giving back part of their business model. Salesforce Ventures has invested in more than 300 enterprise cloud startups in 20 different countries since 2009. For more information, please visit www.salesforce.com/ventures.

Source: https://www.privitar.com/press-releases/series-b-announcement-accel

Feebris raises £1.1 million Seed funding for AI-powered disease diagnosis through 24 Haymarket and Innovate UK

  • The London-based healthtech startup has successfully secured £1.1 million seed funding, in collaboration with investment network 24 Haymarket and Innovate UK
  • Feebris is currently running a pilot with community healthcare workers in India to bring precision diagnosis for respiratory diseases to 10,000 children
  • The startup will also be working with 1,000 elderly patients in the UK to develop AI-powered remote monitoring for COPD and asthma

Founded by Elina Naydenova and Adam Bacon in 2017, and supported by healthtech accelerator HS.Google for StartupsSocial Tech Trust, and White & Case, Feebirs has just raised £1.1 million in seed funding, led by 24 Haymarket and including a grant from Innovate UK.

Feebris is an AI company developing world-class machine learning algorithms for precision detection of complex respiratory conditions in the field. Their software platform pairs with existing medical sensors and can be used intuitively by those with little or no medical training, even outside a clinic environment, to detect respiratory issues.

CEO Dr. Elina Naydenova holds a PhD in Machine Learning for Healthcare Innovation from Oxford University and created the concept for Feebris whilst interning at the World Health Organisation in 2014. “I was shocked that despite being a treatable condition, pneumonia kills one million children under-five every year – more than HIV, malaria, and TB combined. When I realised these deaths can be avoided through early diagnosis, I became obsessed with finding a way to solve the problem.”

Motivated by this, Elina has been working on this technology ever since and was also awarded $100,000 dollars in 2018 by the Children’s Prize Foundation, to scale the work in India.

“By putting our technology into the hands of frontline nurses and care workers, we will power the future of remote precision diagnosis, enabling patients to receive care before they are seriously ill, which means that clinicians are able to focus on patients rather than data. We aim to become a world-leader in the development of CE certified AI for respiratory disease diagnosis and monitoring.

This investment will support Feebris’ AI-enabled platform to continue bridging the gap between the community and providers across a range of respiratory conditions including pneumonia, COPD and asthma.”

Commenting on the investment, Paul Tselentis, CEO of 24Haymarket, said: “Feebris’s cutting-edge AI-platform has the potential to solve one of the most pressing problems in our healthcare systems and provide immense value to patients and physicians alike. This is an exciting time for Feebris; and 24Haymarket are pleased to be supporting them as they build on their early engagement with healthcare providers.”

Feebris supporters also reacted to the investment:

Dr James Somauroo Founding Partner of healthtech accelerator HS. said: “Feebris is a great example of how deep technology has been applied to a problem in healthcare by a very talented founding team with an innovative business model and we’re immensely proud to have been a part of their journey so far. This investment will enable the team to make an impact on a global scale and be a part of fundamentally changing the way that healthcare is delivered around the world, for the better.”

Marta Krupinska, Head of Google for Startups UK said “Feebris is an excellent example of a values-led company that uses technology to solve important social problems, and we’re thrilled that this is recognised by the ecosystem and the investors. We’re really excited to work with Feebris and support them on this next step in their journey”

Ed Evans, CEO of Social Tech Trust said, “We’re thrilled to see Feebris secure seed stage investment to support their growth.  Feebris share our vision for transforming the healthcare system and we see huge potential in their innovative approach.  Driven by passionate founders, I’m confident that Feebris will go on to create incredible social impact.”

About 24 Haymarket: 24Haymarket is a premium deal-by-deal investment platform focused on high-growth businesses, investing up to £5 million in any company. 24Haymarket’s Investor Network includes several highly experienced private equity and venture capital investors, seasoned entrepreneurs and senior operators. These individuals invest their own capital in direct alignment with entrepreneurs and typically seek Board representation to actively support the growth agenda. Since its inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

About HS.: Founded by two doctors, HS. is an accelerator that builds, scales and invests in the best healthtech startups to tackle global health issues. They select talent at all stages and create a bespoke programme for each team – from individuals with ambitious ideas and excellent skillsets, to established companies looking to scale. HS. offers support to build internationally applicable technology from day one, to scale into multiple markets, including the NHS, private healthcare sector, insurance, B2C and emerging markets.

About Google for StartUps: Google for Startups is Google’s initiative to help startups thrive across every corner of the world. We bring the best of Google’s products, connections, and best practices to level the playing field for startup founders and communities, and enable startups to build something better.

About Social Tech Trust: Social Tech Trust’s purpose is to transform lives with tech and they’re dedicated to pursuing their vision of a world where social transformation is the driving force behind tech.  As a leading charity, in the last decade, the Trust has invested over £31 million and supported over 750 socially motivated tech ventures in the UK.

About White & Case: White & Case is a leading global law firm with lawyers in 44 offices across 30 countries. Among the first US-based law firms to establish a truly global presence, we provide counsel and representation in virtually every area of law that affects cross-border business. Our clients value both the breadth of our global network and the depth of our US, English and local law capabilities in each of our regions and rely on us for their complex cross-border transactions, as well as their representation in arbitration and litigation proceedings.

Growth Intelligence has raised £1.7m from 24Haymarket and MMC Ventures

London, UK 23rd January 2018

Growth Intelligence has raised £1.7m to help marketers and sales leaders drive faster growth with AI. Founded in 2013, Growth Intelligence helps high profile brands, including American Express, FedEx, Western Union, iZettle and Vitality Health, target their direct marketing activity to businesses that are most likely to buy. The AI Platform combines records of a client’s previous successful and unsuccessful marketing attempts with Growth Intelligence’s own proprietary data gathered from the digital footprint of every company in the economy, to train an AI for each client. The AI then serves up recommended future clients and advice on how to approach them. It allows sales and marketing teams know who will buy, who will be most valuable, when should they attempt to contact them and what to say when they do.

Growth Intelligence reached profitability early in 2018 and has tripled recurring revenue year on year. The company will use this funding to invest in its AI Platform – building new AIs to solve even more challenges faced by B2B marketers. The company will be investing heavily in data science, engineering and commercial talent.

With demand for Growth Intelligence’s sales and marketing AIs strong and growing, 2019 will see continued triple-digit growth. Growth Intelligence also plans to bring on board leading commercial and technical executives this year.

As part of the investment joining the Board are Andy Robertson, Martin Brown and Stuart Dawson as the chairman.

Thomas Gatten, CEO of Growth Intelligence, adds: “This is a great opportunity to invest on top of our triple-digit revenue growth. Trade is the human super-power, by applying AI to boost trade we are helping companies and economies grow faster. We’re hiring!”

Paul Tselentis, CEO of 24Haymarket, comments: “24Haymarket are thrilled to invest in Growth Intelligence. We have been tracking the company’s progress and its unique approach to improving the productivity of B2B sales and marketing processes for two years. There is an exciting market opportunity ahead of them, as businesses embrace functional AI offerings. We look forward to applying our network to support the team on the next phase of their growth journey.”

Alan Morgan, Chairman, MMC Ventures, adds: “Growth Intelligence is one of a small number of companies using AI to deliver true predictive marketing. We are happy to announce our continued support for the business and look forward to working with Tom, Prash and 24Haymarket in the next phase of their growth.”